IARAX
Price
$16.47
Change
-$0.16 (-0.96%)
Updated
Aug 8 closing price
Net Assets
706.4M
VGSIX
Price
$29.57
Change
-$0.26 (-0.87%)
Updated
Aug 8 closing price
Net Assets
63.72B
Interact to see
Advertisement

IARAX vs VGSIX

Header iconIARAX vs VGSIX Comparison
Open Charts IARAX vs VGSIXBanner chart's image
Invesco Real Estate A
Price$16.47
Change-$0.16 (-0.96%)
VolumeN/A
Net Assets706.4M
Vanguard Real Estate Index Investor
Price$29.57
Change-$0.26 (-0.87%)
VolumeN/A
Net Assets63.72B
IARAX vs VGSIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IARAX vs. VGSIX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IARAX is a Buy and VGSIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGSIX has more cash in the bank: 63.7B vs. IARAX (706M). VGSIX pays higher dividends than IARAX: VGSIX (3.74) vs IARAX (2.16). IARAX was incepted earlier than VGSIX: IARAX (29 years) vs VGSIX (29 years). IARAX (1.38) is less costly to investors than VGSIX (0.27). IARAX is a more actively managed with annual turnover of: 63.00 vs. VGSIX (7.00). VGSIX has a lower initial minimum investment than IARAX: VGSIX (0) vs IARAX (1000). VGSIX annual gain was more profitable for investors over the last year : 1.74 vs. IARAX (-4.74). VGSIX return over 5 years is better than : 29.68 vs. IARAX (-2.61).
IARAXVGSIXIARAX / VGSIX
Total Expense Ratio1.380.27511%
Annual Report Gross Expense Ratio1.380.27511%
Fund Existence29 years29 years-
Gain YTD-1.1851.754-68%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets706M63.7B1%
Annual Yield % from dividends2.163.7458%
Returns for 1 year-4.741.74-272%
Returns for 3 years-17.691.84-963%
Returns for 5 years-2.6129.68-9%
Returns for 10 years-26.7356.84-47%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATRA10.95N/A
-0.05%
Atara Biotherapeutics Inc.
SSD181.31-0.72
-0.40%
Simpson Manufacturing Co
BEAM17.62-0.24
-1.34%
Beam Therapeutics
RCEL4.25-1.13
-21.00%
Avita Medical